Accessibility

At Canvix, we're committed to making our platform accessible to everyone. Learn about our accessibility features and ongoing efforts.

Our Commitment

Canvix is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.

We believe that accessibility is not just about compliance—it's about creating an inclusive environment where everyone can unlock their email potential with our platform.

Accessibility Features

Keyboard Navigation

Full keyboard accessibility with logical tab order and visible focus indicators throughout the email builder.

Screen Reader Support

Semantic HTML structure and ARIA labels to ensure compatibility with screen readers and assistive technologies.

High Contrast Mode

Enhanced color contrast ratios and support for high contrast display modes for better visibility.

Scalable Text

Responsive design that supports browser zoom up to 200% without loss of functionality or content.

Standards & Compliance

We strive to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. Our development team regularly audits our platform to ensure we meet these accessibility requirements.

  • WCAG 2.1 Level AA compliance
  • Section 508 standards adherence
  • Regular accessibility audits and testing
  • Ongoing user feedback integration

Creating Accessible Emails

Canvix helps you create emails that are accessible to all recipients. Our platform includes features and guidance to ensure your email campaigns reach everyone effectively.

Built-in Features

  • Alt text suggestions for images
  • Color contrast checking
  • Semantic HTML structure
  • Accessible table layouts

Best Practices

  • Clear heading hierarchy
  • Descriptive link text
  • Sufficient color contrast
  • Plain text alternatives

We Want Your Feedback

Your feedback helps us improve accessibility for everyone. If you encounter any accessibility barriers while using Canvix, please let us know.